Standout Papers

Maintenance Olaparib for Germline <i>BRCA</i> -Mu... 2012 2026 2016 2021 1.4k
  1. Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer (2019)
    Talia Golan, Pascal Hammel et al. New England Journal of Medicine
  2. Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen (2012)
    Eric Van Cutsem, Josep Tabernero et al. Journal of Clinical Oncology
  3. NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial (2023)
    Zev A. Wainberg, Davide Melisi et al. The Lancet

Immediate Impact

8 from Science/Nature 74 standout
Sub-graph 1 of 21

Citing Papers

Pancreatic cancer
2025 Standout
Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization
2025 Standout

Works of Teresa Macarulla being referenced

Randomized Phase III Study of FOLFOX Alone or With Pegilodecakin as Second-Line Therapy in Patients With Metastatic Pancreatic Cancer That Progressed After Gemcitabine (SEQUOIA)
2021
Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer
2019 Standout
and 5 more

Author Peers

Author Last Decade Papers Cites
Teresa Macarulla 6176 2135 2263 2835 307 8.4k
Robert R. McWilliams 5770 1859 1848 2351 204 8.1k
Zev A. Wainberg 5971 3015 1367 2750 336 9.3k
Teppei Morikawa 5066 2245 1744 3309 204 9.2k
Marcia S. Brose 4456 2031 1396 3514 180 11.1k
Joan Albanell 7586 2802 2674 4709 248 12.1k
Wells A. Messersmith 5215 1753 1640 4246 293 9.3k
Sae‐Won Han 4900 2870 1634 2682 271 7.9k
J. Randolph Hecht 6948 2627 2442 2412 115 9.0k
Gerald S. Falchook 5240 2555 2428 5144 381 10.3k
Laura D. Wood 5015 1518 2836 3010 150 8.2k

All Works

Loading papers...

Rankless by CCL
2026